Easy to use app
- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
IN8bio Inc is a biotechnology business based in the US. IN8bio Inc shares (INAB) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top picks for where to buy In8bio Inc stock
Low margin rates
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
CA & US trading
- 6% cash rebate plus $2,200 in trading perks
- Low transaction fees
- Easy-to-use app
How to buy IN8bio Inc stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – INAB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy IN8bio Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
1 - 6 of 6
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
IN8bio Inc stock price (NASDAQ: INAB)
Use our graph to track the performance of INAB stocks over time.IN8bio Inc stocks at a glance
Information last updated 2024-12-19.
| Latest market close | $0.25 |
|---|---|
| 52-week range | $0.22 - $1.93 |
| 50-day moving average | $0.30 |
| 200-day moving average | $0.72 |
| Wall St. target price | $4.75 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.74 |
Is it a good time to buy IN8bio Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IN8bio Inc price performance over time
Historical closes compared with the close of $0.2488 from 2024-12-20
| 1 week (2024-12-13) | -12.64% |
|---|---|
| 1 month (2024-11-22) | -21.66% |
| 3 months (2024-09-20) | -20.84% |
| 6 months (2024-06-21) | -72.01% |
| 1 year (2023-12-22) | -79.94% |
|---|---|
| 2 years (2022-12-22) | -86.48% |
| 3 years (2021-12-22) | 6.35 |
| 5 years (2019-12-18) | N/A |
IN8bio Inc financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -77.64% |
| Return on equity TTM | -180.45% |
| Profit margin | 0% |
| Book value | $0.58 |
| Market Capitalization | $19.5 million |
TTM: trailing 12 months
IN8bio Inc stock dividends
We're not expecting IN8bio Inc to pay a dividend over the next 12 months.
You may also wish to consider:
IN8bio Inc stock price volatility
Over the last 12 months, IN8bio Inc's stocks have ranged in value from as little as $0.217 up to $1.93. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while IN8bio Inc's is -0.069. This would suggest that IN8bio Inc's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, IN8bio Inc has bucked the trend.
To put IN8bio Inc's beta into context you can compare it against those of similar companies.
- BeiGene (BGNE.US): 0.63
- BioNTech (BNTX.US): 0.259
- Mersana Therapeutics (MRSN.US): 1.475
IN8bio Inc overview
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of solid and liquid tumors. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM and other cancers; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company develops INB-300 and INB-500 that are in preclinical phase for treatment of acute myeloid leukemia, and other solid and hematological tumor types. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020.
Frequently asked questions
What percentage of IN8bio Inc is owned by insiders or institutions?Currently 21.559% of IN8bio Inc stocks are held by insiders and 46.457% by institutions. How many people work for IN8bio Inc?
Latest data suggests 39 work at IN8bio Inc. When does the fiscal year end for IN8bio Inc?
IN8bio Inc's fiscal year ends in December. Where is IN8bio Inc based?
IN8bio Inc's address is: 350 5th Avenue, New York, NY, United States, 10118 What is IN8bio Inc's ISIN number?
IN8bio Inc's international securities identification number is: US45674E1091
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More resources on Finder
More guides on Finder
-
How to buy Raytheon Technologies (RTX) stocks
Steps to owning and managing Raytheon Technologies Corp, with 24-hour and historical pricing before you buy.
-
How to buy Gildan Activewear (GIL) stocks
Steps to owning and managing Gildan Activewear Inc., with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
How to buy IL Makiage stock in Canada when it goes public
Everything we know about the IL Makiage IPO plus information on how to buy in.
-
How to buy ByteDance stock in Canada when it goes public
Everything we know about the ByteDance IPO plus information on how to buy in.
-
How to buy Auvik Networks stock in Canada when it goes public
Everything we know about the Auvik Networks IPO plus information on how to buy in.
-
How to buy goPuff stock in Canada when it goes public
Everything we know about the goPuff IPO plus information on how to buy in.
-
How to buy Universal Music Group (UMG) stock from Canada
If you live in Canada, you need a broker that provides access to foreign investments to buy Universal Music Group stock.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.